AVENAT
"AVENAT" is a word mark owned by Ceapro Inc., filed at the USPTO on July 19, 2024. It is under examination and covers classes 1, 5 and 30.
- Status
- Under examination
- Since June 26, 2026
- Filed
- July 19, 2024
- Registered
- Not yet
- Priority date
- January 19, 2024
- Claimed from Canada
- Application no.
- 98656792
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns AVENAT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ceapro Inc.
Alberta, Canada
Representative
Karl M. Zielaznicki, Esq.
Troutman Pepper Hamilton Sanders LLP
What the mark covers
The products and services AVENAT is filed for, grouped by Nice class.
Active chemical ingredients in the nature of avenanthramides and oat beta glucan for use in the manufacture of cosmeceuticals, nutraceuticals, and pharmaceuticals
(Based on 44(e))(Based on Intent To Use) Dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides for the treatment and prevention of inflammation, inflammatory bowel syndrome, joint inflammation, atherosclerosis, and cancer; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan for modulating glucose metabolism, for preventing and treating metabolic diseases and disorders, and for lowering cholesterol; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering for the treatment of immune-based diseases and disorders of the immune system, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to animal fodder in the nature of dietary supplements for medical purposes; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements; medicinal oils, other than essential oils (Based on Intent To Use) medicated skin care preparations, namely, creams, lotions, and gels; medicated skin care preparations, namely, creams, lotions and gels containing oat beta glucan; bandages for skin wounds; medicated bandages for dressings; bandages impregnated with oat beta glucan for medicinal purposes
Bread; flour and preparations made from cereals, namely, cereal bars, cereal-based snacks, and breakfast cereals; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, and noodles
What has happened so far
Steps recorded by the USPTO, newest first.
- Notification of letter of suspension e-mailed
- Letter of suspension e-mailed
- Suspension letter written
- Teas/email correspondence entered
- Correspondence received in law office
- Assigned to lie
- Teas response to suspension inquiry received
- Notification of inquiry as to suspension e-mailed
- Inquiry to suspension e-mailed
- Suspension inquiry written
10 earlier steps on the official record.
About AVENAT
Who owns the trademark "AVENAT"?
The USPTO trademark "AVENAT" (application 98656792) is owned by Ceapro Inc.
What is the status of "AVENAT"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull AVENAT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2943-14cd-75c9-8e70-6dd4c2d9b843
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2943-14cd-75c9-8e70-6dd4c2d9b843",
"object": "trademark",
"mark_text": "AVENAT",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "98656792",
"filing_date": "2024-07-19",
"nice_classes": [
1,
5,
30
],
"owners": [
{
"name": "Ceapro Inc.",
"entity_id": "ent_019eb7b0-a0fa-72c2-83a7-be36fe6ffe8c"
}
]
}